For each valve, total RNA from a single aortic valve cusp was extracted using the
TRIzol LS (Invitrogen, Carlsbad, CA, USA) method and digested with
RNase free DNase I (Invitrogen).
For PESA and CAVD validation total RNA was using either the
PAXgene blood mRNA kit (PreAnalytiX, Hombrechtikon, Switzerland) for manual isolation or the QIAsymphony PAXgene blood RNA kit (PreAnalytiX) for automated isolation using a QIAsymphony SP liquid handling robot (Qiagen, Venlo, Netherlands). RNA purity, concentration, and integrity were assessed by
Nanodrop 2000 spectrophotometry (Thermo Scientific) and automated electrophoresis in a 2100
Bioanalyzer (RNA6000 Nano LabChip; Agilent). Samples with a RIN > 6 were selected for reverse transcription.
MacGrogan D., Martínez-Poveda B., Desvignes J.P., Fernandez-Friera L., Gomez M.J., Gil Vilariño E., Callejas Alejano S., Garcia-Pavia P., Solis J., Lucena J., Salgado D., Collod-Béroud G., Faure E., Théron A., Torrents J., Avierinos J.F., Montes L., Dopazo A., Fuster V., Ibañez B., Sánchez-Cabo F., Zaffran S, & de la Pompa J.L. (2020). Identification of a peripheral blood gene signature predicting aortic valve calcification. Physiological genomics, 52(12).